The gap between knowing what you should do and actually doing it is the most popular real estate I work in. People don’t come in confused about what would help. They come in exhausted from watching themselves not do it. They know they should call the dentist, email their old boss, cancel the gym membership that’s been bleeding money since March. They’ve known for months. Sometimes years.
The intention is fine. The intention has been fine the whole time. Something between the intention and the body is where the wheel comes off, and that gap is where a lot of adult suffering lives. Right after the insight, where you’re supposed to stand up and move, the signal stops getting through. Most of what I do all day is help people close that gap by about ten percent. Usually by figuring out what’s jamming the lever and either treating it with the right medication, naming it honestly, or shrinking the first step until it’s small enough that the lever finally moves.
Specificity is the difference between a plan and a wish, and most people have wishes and call them plans.
Why the lever jams
There are a handful of usual suspects, and most patients have at least two of them running at once. Depression flattens the reward circuit so nothing on the to-do list registers as worth getting up for. ADHD makes future consequences feel like rumors instead of facts, which is why the Friday 4 PM deadline doesn’t move you at noon Wednesday even when you know it should. Anxiety makes the first step feel like the whole staircase. And there’s the boring version where somebody is just chronically under-slept, drinking too much coffee, and has been telling themselves for six months they’ll “get organized this weekend.”
The ADHD version is the most common one. The kind of guy who walks in convinced he’s lazy turns out to have a list on his phone of 40-plus things he’s been meaning to do, some of them sitting there since 2021. He runs a team at work where everything gets done by the deadline, and at home he can’t book a dental cleaning, the contrast itself is the diagnosis. Start him on a low dose of a stimulant plus a few sessions of behavioral work, and eight weeks later he’s crossed off fourteen items including the dental cleaning he’d been postponing since the pandemic. The bottleneck wasn’t motivation, the bottleneck was that low-stakes tasks weren’t generating enough internal signal for him to start them. Once we shortened the distance between “I should do this” and “I’m doing this,” the list became a normal list.
The depressed version looks different. Picture a patient who hasn’t opened his personal email in four months and just stopped caring whether anything got answered. Wellbutrin at 150mg, bumped to 300mg at week three, by week six he’s opening mail again. Once the floor of his mood came up, clicking on a folder stopped costing more than it returned. Not magic. Just lifting the floor enough that small actions stopped being expensive.
Anxiety jams the lever a third way. The first step doesn’t feel small, it feels like a referendum on your whole identity. Sending one email feels like risking the whole professional relationship, so you don’t send it, and your brain learns that dodging the email was the right call, which means tomorrow it’ll be even harder. This is how a thirty-second task ages into a six-month problem.
The boring evidence-based thing that works
There’s a treatment for the gap. It’s been studied since the seventies and it’s almost embarrassingly simple. The idea is that motivation usually shows up after the action, not before. You do the thing first, even at a tiny dose, and the motivation arrives roughly twenty to forty minutes in, because your brain finally has evidence that the thing was survivable.
People wait for the motivation because that’s how we describe things in stories. “I felt inspired and then I started painting.” Usually what actually happened is the person picked up a brush feeling nothing in particular, and ten minutes in, the painting started talking back to them, and they call that inspiration in retrospect. Mood tends to follow behavior more reliably than the other way around. One of the better-replicated findings in the field, and almost nobody applies it to themselves.
You stop trying to want to do the thing. You schedule the thing. You make the dose small enough your nervous system doesn’t flinch.
What this looks like in practice: you stop trying to want to do the thing, you schedule the thing, you make the dose small enough your nervous system doesn’t flinch. Dishes for five minutes instead of all of them, one paragraph of the email instead of the whole reply, a walk to the end of the block instead of a run. The trick is making the first action small enough that the part of your brain looking for reasons to bail can’t get a grip on it.
Then you do it again the next day, and the next. About two weeks in, the size of the action you can tolerate roughly doubles, because you’ve stacked evidence that doing the thing didn’t kill you. That’s the engine. The guys who get unstuck aren’t more motivated than you, they’ve just stopped negotiating with themselves about whether to start. The negotiation is the avoidance. The schedule is what kills the negotiation.

Where medication actually fits
Medication doesn’t generate motion by itself, what it does is clear out the stuff making motion expensive in the first place.
If depression is the reason your reward circuit’s gone quiet, an antidepressant brings the floor up enough that small actions register again. SSRIs (selective serotonin reuptake inhibitors, the standard antidepressant class, Zoloft 50-100mg or Lexapro 10-20mg) for the anxious-depressed flavor of it, Wellbutrin (the bupropion XL version, 150-300mg) when motivation and energy are the worst symptoms. Takes four to six weeks. Don’t quit at week two when the side effects peak and the benefit hasn’t shown up yet. That timing is the single most common reason people decide their first antidepressant trial failed when actually it had not yet started.
If ADHD is the reason future consequences don’t move you in the present, a stimulant (Vyvanse 30-70mg, Adderall XR 10-30mg, or methylphenidate variants) makes the lever lighter. People worry stimulants will turn them into somebody else. They mostly don’t, what they do is shorten the distance between “I should do this” and “I’m doing this” from forty minutes of internal negotiation to about four. Vyvanse is my personal favorite of the bunch, I’m on it myself, it works. On the cardiac side, because somebody has to say it: stimulants reliably raise your blood pressure and heart rate, and a first-time-stimulant-at-fifty conversation is genuinely fraught. Anyone on multiple cardiac meds is an iffy candidate, anyone with uncontrolled hypertension needs that handled first, and any prescriber telling you stimulants are completely safe in cardiac patients is a damn liar. With proper screening it’s manageable, without proper screening it’s not.
If anxiety is the reason every first step feels like a public referendum, an SSRI brings the volume down enough that the cost of starting becomes something you can pay. None of these drugs do the work for you, they make the work doable. Patients sometimes wait for the medication to deliver the action itself, then conclude it’s failed when their week still has friction in it. Friction is normal. The drug’s job is to make it passable.
On the patient-autonomy piece, because I get asked: if you want to try a medication and we’ve done the workup honestly, you get the prescription. I’m a provider, not a parent. About 60 percent of my patients end up not on medication, not because I refused but because we talked about it and they decided to see what they could do without it first. That’s a perfectly reasonable answer when nobody is in crisis, and the choice is yours either way.
Shrink the first step
If the task is “clean the kitchen,” the actual first step is “stand at the sink for two minutes.” Make it so small your brain can’t object. The next step will appear.
Pick the hour, not the mood
Schedule it for Tuesday at 7 PM. Don’t wait until you feel like it. You won’t. The mood arrives about twenty minutes into doing the thing, not before.
Two weeks, same dose
Do the small version every day for fourteen days before you scale up. Most people quit on day four because the action feels too small. That smallness is the whole point.

What I tell people on day one
Pick one thing. Not five. One. Make the first try small enough that you’d be embarrassed to describe it to a friend. That embarrassment is exactly the right dose. The version of the task that sounds impressive is the version you won’t do, and the version that sounds pathetic is the version that will actually move you.
Then put it on a calendar with an actual time on it. “Tomorrow morning, 8:15, I’ll open the bank app for two minutes.” Not “I’ll deal with my finances this week.” Specificity is the difference between a plan and a wish, and most people have wishes and call them plans.
And then watch what happens to the story you tell yourself about yourself. After about two weeks of doing the small version, the internal narrative starts shifting from “I’m somebody who can’t get my act together” to “I’m somebody who does this thing now.” That shift is most of the prize. You’re rebuilding the part of yourself that trusts you to follow through, stacking small honored commitments until the pattern of self-betrayal starts to crack.
If you’ve been stuck on the same thing for more than three months, another productivity book from your cousin’s TikTok algorithm isn’t going to move you. Figuring out what’s jamming the lever might, and that conversation often belongs in a clinical office rather than in your own head at 11 PM. People are bad at diagnosing their own intention-action gap because the same brain that’s stuck is the one doing the diagnosing. Wait, can I say that out loud? Yes, because if it were easy to figure out yourself you’d have figured it out by now.
Sources
- Ekers D, Webster L, Van Straten A, Cuijpers P, Richards D, Gilbody S. Behavioural activation for depression; an update of meta-analysis of effectiveness and sub group analysis. PLoS One. 2014;9(6):e100100. PMID 24936656.
- Uphoff E, Ekers D, Robertson L, et al. Behavioural activation therapy for depression in adults. Cochrane Database Syst Rev. 2020;7(7):CD013305. PMID 32628293.
- Cortese S, Adamo N, Del Giovane C, et al. Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder. Lancet Psychiatry. 2018;5(9):727-738. PMID 30097390.